Not applicableStudy completedNCT01341665What this trial is testingSubclassification of the Syndrome of Inappropriate ADH SecretionWho this might be right forHyponatremia University of Wuerzburg 50
Large-scale testing (Phase 3)Study completedNCT02874807What this trial is testingEffects of the SGLT2-inhibitor Empagliflozin on Patients With SIADH - the SAND StudyWho this might be right forSIADH University Hospital, Basel, Switzerland 88
Not applicableUnknownNCT01509170What this trial is testingThe Clinical and Laboratory Characteristics of Recurrent Drug- Related HyponatremiaWho this might be right forHyponatremiaSIADH Hadassah Medical Organization 500
Not applicableStudy completedNCT01465672What this trial is testingCopeptin as a Diagnostic Marker in the Management of Neurosurgical Patients With Disturbance of Water HomeostasisWho this might be right forPituitary Adenoma University Hospital, Basel, Switzerland 125
Not applicableStudy completedNCT01313975What this trial is testingElectrolyte and Fluid Disturbances in Subarachnoid Hemorrhage and Traumatic Brain InjuryWho this might be right forElectrolyte DisturbancesSubarachnoid HemorrhageTraumatic Brain Injury+1 more Insel Gruppe AG, University Hospital Bern 85
Not applicableLooking for participantsNCT07528365What this trial is testingUrea for Treatment of Hyponatremia in Patients With SIAD Unresponsive to Fluid RestrictionWho this might be right forSIAD - Syndrome of Inappropriate Antidiuresis University of Turin, Italy 20
Large-scale testing (Phase 3)Study completedNCT00072683What this trial is testing"SALT Trial" Study of Ascending Levels of Tolvaptan in HyponatremiaWho this might be right forHyponatremiasWater IntoxicationInappropriate ADH Syndrome+1 more Otsuka Pharmaceutical Development & Commercialization, Inc. 240
Large-scale testing (Phase 3)Ended earlyNCT01227512What this trial is testingEffects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional HyponatremiaWho this might be right forHyponatremiaDilutional HyponatremiaInappropriate ADH Syndrome Otsuka Pharmaceutical Development & Commercialization, Inc. 124
Large-scale testing (Phase 3)Study completedNCT00876798What this trial is testingA Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of Oral Lixivaptan Capsules in Subjects With Euvolemic HyponatremiaWho this might be right forEuvolemic Hyponatremia CardioKine Inc. 206
Not applicableUnknownNCT01228682What this trial is testingPost-Authorisation Safety Study of Samsca (Tolvaptan) Used in Routine Medical PracticeWho this might be right forSIADHNon-SIADH HyponatremiaNon-Hyponatremia Otsuka Frankfurt Research Institute GmbH 200
Not applicableStudy completedNCT04987385What this trial is testingEffect of Protein Supplementation on Plasma Sodium Levels and Urinary Urea Excretion in Patients With SIADWho this might be right forSyndrome of Inappropriate Antidiuresis (SIAD) University Hospital, Basel, Switzerland 18
Post-approval studies (Phase 4)Looking for participantsNCT04447911What this trial is testingEffects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic HyponatremiaWho this might be right forHyponatremiaSIADHLiver Failure+1 more University Hospital, Basel, Switzerland 172
Not applicableStudy completedNCT01056848What this trial is testingInternational, Multicenter Study of a Twenty-eight Week, Open-label, Titrated Oral Lixivaptan Administration in Patients With Chronic Hyponatremia: Extension to Studies CK-LX3401, 3405, and 3430Who this might be right forHyponatremia With Normal Extracellular Fluid VolumeHyponatremia With Excess Extracellular Fluid Volume CardioKine Inc. 135
Testing effectiveness (Phase 2)Study completedNCT02009878What this trial is testingA PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)Who this might be right forSyndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Otsuka Pharmaceutical Development & Commercialization, Inc. 30
Large-scale testing (Phase 3)Study completedNCT00201994What this trial is testing"SALT-2 Trial" Study of Ascending Levels of Tolvaptan in HyponatremiaWho this might be right forHyponatremiaWater IntoxicationInappropriate ADH Syndrome+1 more Otsuka Pharmaceutical Development & Commercialization, Inc. 243
Not applicableStudy completedNCT04119206What this trial is testingTolvaptan Versus Fluid Restriction in SIADHWho this might be right forHyponatremiaSyndrome of Inappropriate ADH (SIADH) SecretionPituitary University of Erlangen-Nürnberg Medical School 334
Not applicableStudy completedNCT00390962What this trial is testingThe "COSMOS"-Study (Copeptin in Osmoregulation and Stress Assessment)Who this might be right forStrokeTransient Ischemic Attack University Hospital, Basel, Switzerland 469
Large-scale testing (Phase 3)Ended earlyNCT00728091What this trial is testingA Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional HyponatremiaWho this might be right forHyponatremiaInappropriate ADH Syndrome Sanofi 2
Not applicableStudy completedNCT04256499What this trial is testingWater Load Test Value for HyponatremiaWho this might be right forSIAD - Syndrome of Inappropriate AntidiuresisHyponatremia European Georges Pompidou Hospital 150
Large-scale testing (Phase 3)Study completedNCT02729766What this trial is testingEffects of Empagliflozin an SGLT2-Inhibitor on Healthy Volunteers With Induced Hypotonic Hyponatremia - the DIVE StudyWho this might be right forInappropriate ADH Syndrome University Hospital, Basel, Switzerland 15